Cureline is a global translational and precision medicine Contract Research Organization (CRO) based in South San Francisco, California. Since its establishment in 2003, Cureline has been providing comprehensive biobanking and laboratory services for accelerated drug research and development (R&D) and diagnostic (Dx) development. With a collaborative approach to project management, Cureline offers standard and custom protocols and services, precision medicine expertise in major therapeutic areas, and a global clinical network and regulatory expertise.
As a trusted partner in HBS validation studies, Cureline specializes in the procurement of high-quality human biospecimens, including fresh human tissue, blood, biofluids, and frozen hematology cells. They also offer validated HBS sets for biomarker development, immuno-oncology HBS ready for functional assays, normal control HBS from healthy donors, and analytical services for histology and molecular analysis. With over 150 validated clinical partners in 20 countries, Cureline has a strong track record of completing projects for satisfied clients and has participated in major scientific consortiums such as the TCGA and the CPTAC.
Generated from the website